Chinese infant formula group Synutra International said it was “pleased” with the performance and ongoing recovery of its core business as it booked an increase in first-quarter earnings and sales.
Net income in the first six months of the year to the end of June, reached US$4.8m from $3.3m last year. Operating profit edged up 3% to $6.9m.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
CEO Liang Zhang said the profit growth was despite “a seasonally slower period”.
“We continued to strengthen the sales operation in our core branded powdered formula segment and also experienced significant results within our nutritional ingredients segment,” he said. “As our sales organization and outlet network continued to stabilize, we experienced year-over-year as well as sequential increases to both our shipment volume and average selling price.”
Net sales in the period increased 13% to $82.2m.
Click here to view the full earnings release.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
